Today I’ll show you, once again, why supply and demand govern all markets, and why price action—pure and simple—is still the most powerful trading tool you’ll ever use.We’re looking at Smith & Wesson Brands, SWBI, and you’ll see two weekly imbalances created and respected as if the chart were whispering: ‘Follow the big boys… forget...
Ford Motors currently offers one of the cleanest supply-and-demand structures in the stock market. The bigger timeframes — monthly and weekly — are in full control, and as price reacts to these higher-timeframe imbalances, new daily demand levels are forming with exceptional strength. This is exactly how professional price action develops: the higher timeframes establish...
Microsoft just did what every impatient trader hates… after a massive rally, the candles are shrinking, emotions are rising, and here comes the correction everyone said ‘couldn’t happen.’ Today I’ll show you—using pure supply and demand—why MSFT is being magnetically pulled back into the monthly demand imbalance like a toddler to a candy shop. No...
Hey traders! Alfonso here. Apple. Yes, one of the most liquid, most loved, and most worshipped stocks on the planet is about to teach retail traders a very expensive lesson. And no, you don’t need fundamentals, Bloomberg breaks, or Tim Cook whispers. You just need supply and demand imbalances, price action… and a little patience...
Palantir has been the superhero of Wall Street this year… up more than 250%. But here’s the uncomfortable truth nobody wants to hear: If you buy now, you’re not a genius… you’re late. Very late. In today’s stock video analysis, I’ll show you exactly where the real buy zones are on the monthly and weekly...
Pfizer just did it again! After a few weeks of sleeping inside that weekly demand imbalance, the pharmaceutical giant exploded — exactly as expected from our supply and demand forecast. Price has already rallied more than 7%, proving once again how powerful these imbalances can be when you learn to read them properly. Let’s dive...
Hey traders, I’m diving into one of the most famous pharmaceutical giants on the planet — Pfizer. Yes, that Pfizer. Love them or hate them, the chart doesn’t lie. The weekly timeframe just gave us a brand-new demand imbalance, and it’s looking ready to roar. Let’s break it down and see if Pfizer could be...
Before you hit that “Buy” button on Tesla stock because it looks strong, take a deep breath and back away from the keyboard. Today’s supply and demand stock analysis focuses on why Tesla stock is NOT a buy right now, despite a new daily demand zone just being created at $360 per share. I’ll also walk you...